AstraZeneca says interim net profit rises 23 pct

LONDON - Anglo-Swedish pharmaceuticals giant AstraZeneca said Thursday its first-half net profit rose 23.4 percent to 3.853 billion dollars (2.738 billion euros) despite the global downturn.

By (AFP)

  • Follow us on
  • google-news
  • whatsapp
  • telegram

Published: Thu 30 Jul 2009, 6:35 PM

Last updated: Sun 5 Apr 2015, 10:33 PM

AstraZeneca added in a results statement that total revenues rose 0.2 percent to reach 15.659 billion dollars in the six months to the end of June, compared with the same portion of 2008.

‘Our business performance, in the context of tough global economic conditions, has been better than we anticipated,’ said Chief Executive David Brennan in the earnings release.

The company said it was boosted by strong sales of the cholesterol drug Crestor and hypertension treatment Toprol XL.

Following publication of the results, AstraZeneca’s share price rose 2.21 percent at 2,865 pence on London’s FTSE 100 index, which was up 1.26 percent at 4,604.84 points.

More news from